MedPlus Health Services Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
November 11, 2022 at 12:52 pm IST
Share
MedPlus Health Services Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 11,206.25 million compared to INR 9,247.38 million a year ago. Revenue was INR 11,315.18 million compared to INR 9,315.08 million a year ago. Net income was INR 65.65 million compared to INR 203.13 million a year ago. Basic earnings per share from continuing operations was INR 0.55 compared to INR 1.85 a year ago. Diluted earnings per share from continuing operations was INR 0.55 compared to INR 1.82 a year ago.
For the six months, sales was INR 21,142.79 million compared to INR 18,799.21 million a year ago. Revenue was INR 21,353.02 million compared to INR 18,908.99 million a year ago. Net income was INR 97.65 million compared to INR 669.01 million a year ago. Basic earnings per share from continuing operations was INR 0.91 compared to INR 6.16 a year ago. Diluted earnings per share from continuing operations was INR 0.87 compared to INR 5.99 a year ago.
MedPlus Health Services Limited is an India-based omni channel retail pharmacy. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through two segments: Retail and Diagnostics. The Retail segment is engaged in retail trading of medicines and general items. The Diagnostics segment is engaged in the diagnostic services. The Company operates approximately 3,882 stores in 552 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its subsidiaries include Optival Health Solutions Private Limited, MHS Pharmaceuticals Private Limited, Kalyani Meditimes Private Limited, and others.